<?xml version="1.0" encoding="UTF-8" ?> 
<rss version="2.0"> 
<channel> 
  <title>소송 보도자료 - 뉴스와이어</title>  
  <link>https://www.newswire.co.kr/?md=A02&amp;cat=124</link>  
  <description>소송 보도자료 - 뉴스와이어 RSS 서비스</description>  
  <lastBuildDate>Tue, 07 Jul 2026 13:48:23 +0900</lastBuildDate>  
  <copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright>  
  <webMaster>gichan2@newswire.co.kr</webMaster>  
  <language>ko</language>  
 <image> 
  <title>Newswire</title>  
  <url>https://static.newswire.co.kr/images/logo/logo_rss.png</url>  
  <link>https://www.newswire.co.kr</link>  
  <description>Newswire - 보도자료 통신사 뉴스와이어</description>  
 </image> 
  <item> 
  <title> 
  <![CDATA[Court Clears Biocytogen’s RenNano® in Landmark Patent Dispute Against Harbour]]> 
  </title> 
  <link>https://www.newswire.co.kr/newsRead.php?no=1037700&amp;sourceType=rss</link> 
  <category></category> 
  <description> 
  <![CDATA[<table border=0 align=left cellspacing=0 cellpadding=0 cellpadding=3 style='font-size:100%;font-family:arial,sans-serif'><tr><td width=80 align=center style='padding-left:6px;' valign=top><a href='https://www.newswire.co.kr/newsRead.php?no=&amp;sourceType=rss' target=nw><img src="https://file.newswire.co.kr/data/datafile2/thumb/2026/07/1028147215_20260701094701_1942772410.jpg" width="80" border="0" /></a></td></tr></table>BEIJING--(Business Wire/Korea Newswire)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen,” SSE: 688796; HKEX: 02315) today announced that it has received a first-instance civil judgment from the Shanghai Intellectual Property Court. Th...]]> 
  </description> 
  <pubDate>Wed, 01 Jul 2026 10:15:00 +0900</pubDate> 
  </item> 
  <item> 
  <title> 
  <![CDATA[바이오사이토젠, 하버와의 특허 분쟁에서 렌나노® 승소 판결 받아]]> 
  </title> 
  <link>https://www.newswire.co.kr/newsRead.php?no=1037704&amp;sourceType=rss</link> 
  <category></category> 
  <description> 
  <![CDATA[베이징, 중국--(Business Wire/뉴스와이어)--바이오사이토젠 파마슈티컬스(베이징)(Biocytogen Pharmaceuticals (Beijing) Co., Ltd.)(바이오사이토젠(Biocytogen), SSE: 688796; HKEX: 02315)가 상해지적재산권법원(Shanghai Intellectual Property Court)으로부터 ...]]> 
  </description> 
  <pubDate>Wed, 01 Jul 2026 10:15:00 +0900</pubDate> 
  </item> 
  <item> 
  <title> 
  <![CDATA[Seiden Law LLP States: Cambodian Businessman Leak Yim, Wrongfully Accused in Thailand, Seeks Redress in U.S. Court]]> 
  </title> 
  <link>https://www.newswire.co.kr/newsRead.php?no=1037591&amp;sourceType=rss</link> 
  <category></category> 
  <description> 
  <![CDATA[SINGAPORE--(Business Wire/Korea Newswire)--Seiden Law LLP (“Seiden Law”), legal counsel for Mr. Leak Yim, a Cambodia national, and his family, announces the filing of an application in U.S. federal district court in Washington D.C., seeking court-...]]> 
  </description> 
  <pubDate>Tue, 30 Jun 2026 09:30:00 +0900</pubDate> 
  </item> 
  <item> 
  <title> 
  <![CDATA[사이든 로 ‘태국에서 부당하게 기소된 캄보디아 사업가 릭 임, 미국 법원에 구제 청구’]]> 
  </title> 
  <link>https://www.newswire.co.kr/newsRead.php?no=1037593&amp;sourceType=rss</link> 
  <category></category> 
  <description> 
  <![CDATA[싱가포르--(Business Wire/뉴스와이어)--캄보디아 국적의 릭 임(Leak Yim)과 그의 가족의 법률 대리인인 사이든 로(Seiden Law LLP, 사이든 로)가 미국 워싱턴 D.C. 연방지방법원에 증거 수집을 위한 신청서를 제출했다고 밝혔다. 이번 신청은 태국에서 임 씨를 상대...]]> 
  </description> 
  <pubDate>Tue, 30 Jun 2026 09:30:00 +0900</pubDate> 
  </item> 
  <item> 
  <title> 
  <![CDATA[Beerenberg Prevails in Patent Case Against Aspen Aerogels]]> 
  </title> 
  <link>https://www.newswire.co.kr/newsRead.php?no=1037558&amp;sourceType=rss</link> 
  <category></category> 
  <description> 
  <![CDATA[<table border=0 align=left cellspacing=0 cellpadding=0 cellpadding=3 style='font-size:100%;font-family:arial,sans-serif'><tr><td width=80 align=center style='padding-left:6px;' valign=top><a href='https://www.newswire.co.kr/newsRead.php?no=&amp;sourceType=rss' target=nw><img src="https://file.newswire.co.kr/data/datafile2/thumb/2026/06/1028147215_20260629151216_4979698518.jpg" width="80" border="0" /></a></td></tr></table>SEOUL, South Korea--(Business Wire/Korea Newswire)--The Korean Patent Court has invalidated three of Aspen Aerogels’ patents related to improved hydrophobic aerogel material. The ruling confirms the conclusion of the Intellectual Property Trial an...]]> 
  </description> 
  <pubDate>Mon, 29 Jun 2026 15:30:00 +0900</pubDate> 
  </item> 
  <item> 
  <title> 
  <![CDATA[비어렌버그, 아스펜 에어로젤스 상대로 한 특허 소송에서 승소]]> 
  </title> 
  <link>https://www.newswire.co.kr/newsRead.php?no=1037559&amp;sourceType=rss</link> 
  <category></category> 
  <description> 
  <![CDATA[서울--(Business Wire/뉴스와이어)--한국 특허법원은 개선된 소수성 에어로젤 소재와 관련한 아스펜 에어로젤스(Aspen Aerogels)의 특허 3건을 무효로 판결했다. 이번 판결은 해당 특허가 특허 적격성에 필요한 요건을 충족하지 못했다는 특허심판원(Intellectual Pr...]]> 
  </description> 
  <pubDate>Mon, 29 Jun 2026 15:30:00 +0900</pubDate> 
  </item> 
  <item> 
  <title> 
  <![CDATA[Angelalign Technology Inc. (6699.HK) Applauds European Court Rejection of Patent Infringement Claim]]> 
  </title> 
  <link>https://www.newswire.co.kr/newsRead.php?no=1034428&amp;sourceType=rss</link> 
  <category></category> 
  <description> 
  <![CDATA[SAN CLEMENTE, Calif.--(Business Wire/Korea Newswire)--Angelalign Technology Inc. (6699.HK) (“Angel”)  today said it was grateful that the Local Division Düsseldorf (Germany) of the Unified Patent Court rejected a request by Align Technology Inc. (...]]> 
  </description> 
  <pubDate>Thu, 14 May 2026 09:30:00 +0900</pubDate> 
  </item> 
  <item> 
  <title> 
  <![CDATA[앤젤얼라인 테크놀로지, 유럽 법원의 특허 침해 소송 기각 결정 환영]]> 
  </title> 
  <link>https://www.newswire.co.kr/newsRead.php?no=1034433&amp;sourceType=rss</link> 
  <category></category> 
  <description> 
  <![CDATA[샌클레멘테, 캘리포니아--(Business Wire/뉴스와이어)--앤젤얼라인 테크놀로지(Angelalign Technology Inc., 이하 앤젤)(6699.HK)는 독일 뒤셀도르프 지방 통합특허법원이 얼라인 테크놀로지(Align Technology Inc.)(ALGN)가 앤젤에게 자사의 A7 소구치 발치 솔루션...]]> 
  </description> 
  <pubDate>Thu, 14 May 2026 09:30:00 +0900</pubDate> 
  </item> 
  <item> 
  <title> 
  <![CDATA[Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health]]> 
  </title> 
  <link>https://www.newswire.co.kr/newsRead.php?no=1033236&amp;sourceType=rss</link> 
  <category></category> 
  <description> 
  <![CDATA[<table border=0 align=left cellspacing=0 cellpadding=0 cellpadding=3 style='font-size:100%;font-family:arial,sans-serif'><tr><td width=80 align=center style='padding-left:6px;' valign=top><a href='https://www.newswire.co.kr/newsRead.php?no=&amp;sourceType=rss' target=nw><img src="https://file.newswire.co.kr/data/datafile2/thumb/2026/04/31017998_20260427145109_1846039817.jpg" width="80" border="0" /></a></td></tr></table>VIENNA--(Business Wire/Korea Newswire)--Today, the Higher Regional Court of Frankfurt upheld the February 2025[1] partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. ...]]> 
  </description> 
  <pubDate>Mon, 27 Apr 2026 15:20:00 +0900</pubDate> 
  </item> 
  <item> 
  <title> 
  <![CDATA[프랑크푸르트 고등법원, AOP 헬스에 유리한 BESREMi® 중재 판정 유지]]> 
  </title> 
  <link>https://www.newswire.co.kr/newsRead.php?no=1033240&amp;sourceType=rss</link> 
  <category></category> 
  <description> 
  <![CDATA[빈--(Business Wire/뉴스와이어)--프랑크푸르트 고등법원(Higher Regional Court of Frankfurt)은 AOP 오펀 파마큐티컬스(AOP Orphan Pharmaceuticals GmbH, 이하 ‘AOP 헬스’)와 파마에센시아(PharmaEssentia Corp., 이하 ‘파마에센시아’) 간의 분쟁에서 AOP 헬스에 ...]]> 
  </description> 
  <pubDate>Mon, 27 Apr 2026 15:20:00 +0900</pubDate> 
  </item> 
  <item> 
  <title> 
  <![CDATA[Venture Global and Edison Announce Calcasieu Pass Arbitration Settlement]]> 
  </title> 
  <link>https://www.newswire.co.kr/newsRead.php?no=1031255&amp;sourceType=rss</link> 
  <category></category> 
  <description> 
  <![CDATA[<table border=0 align=left cellspacing=0 cellpadding=0 cellpadding=3 style='font-size:100%;font-family:arial,sans-serif'><tr><td width=80 align=center style='padding-left:6px;' valign=top><a href='https://www.newswire.co.kr/newsRead.php?no=&amp;sourceType=rss' target=nw><img src="https://file.newswire.co.kr/data/datafile2/thumb/2026/03/31017998_20260329101914_5664586081.jpg" width="80" border="0" /></a></td></tr></table>ARLINGTON, Va. & MILAN--(Business Wire/Korea Newswire)--Today, Venture Global and Edison jointly announced the signature of a commercial agreement for the settlement of the pending arbitration between the two companies concerning the Calcasieu Pas...]]> 
  </description> 
  <pubDate>Sun, 29 Mar 2026 10:30:00 +0900</pubDate> 
  </item> 
  <item> 
  <title> 
  <![CDATA[벤처글로벌과 에디슨, 칼카시우 패스 중재 합의 발표]]> 
  </title> 
  <link>https://www.newswire.co.kr/newsRead.php?no=1031256&amp;sourceType=rss</link> 
  <category></category> 
  <description> 
  <![CDATA[알링턴, 버지니아 및 밀라노--(Business Wire/뉴스와이어)--벤처글로벌(Venture Global)과 에디슨(Edison)은 칼카시우 패스(Calcasieu Pass) 프로젝트와 관련하여 양사 간에 진행 중이던 중재에 합의하는 상업 계약을 체결했다고 공동 발표했다. 합의는 2026년 2분기...]]> 
  </description> 
  <pubDate>Sun, 29 Mar 2026 10:30:00 +0900</pubDate> 
  </item> 
  <item> 
  <title> 
  <![CDATA[Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery]]> 
  </title> 
  <link>https://www.newswire.co.kr/newsRead.php?no=1031146&amp;sourceType=rss</link> 
  <category></category> 
  <description> 
  <![CDATA[MATAWAN, N.J. & SEOUL, South Korea--(Business Wire/Korea Newswire)--MindWave Innovations Inc., a Delaware corporation and wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc. (“APUS” or the “Company”) (NYSE American: APUS), today announced ...]]> 
  </description> 
  <pubDate>Thu, 26 Mar 2026 16:30:00 +0900</pubDate> 
  </item> 
  <item> 
  <title> 
  <![CDATA[아피메즈 파마슈티컬스 US, 인스코비와 아피메즈의 합병 계약에 중대한 위반 발표… 델라웨어 형평법원에 긴급 소송 제기 준비]]> 
  </title> 
  <link>https://www.newswire.co.kr/newsRead.php?no=1031149&amp;sourceType=rss</link> 
  <category></category> 
  <description> 
  <![CDATA[마타완, 뉴저지 & 서울--(Business Wire/뉴스와이어)--미국 델라웨어에 위치한 법인이자 아피메즈 파마슈티컬스 US(Apimeds Pharmaceuticals US, Inc., 이하 APUS 또는 회사)(NYSE American: APUS)의 전액 출자 자회사인 마인드웨이브 이노베이션스(MindWave Innovat...]]> 
  </description> 
  <pubDate>Thu, 26 Mar 2026 16:30:00 +0900</pubDate> 
  </item> 
  <item> 
  <title> 
  <![CDATA[Greenoaks and Altimeter withdraw Section 301 Petition as Administration Holds Korea Accountable and Announces its Intention to Advance Broad Section 301 Actions]]> 
  </title> 
  <link>https://www.newswire.co.kr/newsRead.php?no=1030002&amp;sourceType=rss</link> 
  <category></category> 
  <description> 
  <![CDATA[SAN FRANCISCO--(Business Wire/Korea Newswire)--Greenoaks and Altimeter today announced that we have withdrawn our Section 301 petition concerning the Government of the Republic of Korea’s treatment of Coupang, Inc. Our potential action under the U...]]> 
  </description> 
  <pubDate>Tue, 10 Mar 2026 15:20:00 +0900</pubDate> 
  </item> 
</channel> 
</rss> 
